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The modern scientific society has presently recognized flavonoids to be a unique class of therapeutic molecules due to 
their varied therapeutic properties. Of these, hesperidin, found along with vitamin C, has been explored for a number of 
pharmacological effects. Citrus and oranges possess hesperidin as one of the active constituents. Today, hesperidin has been 
well recognized for its beneficial effects on health. The present review highlights the current information and health-
promoting effects of hesperidin. The review uncovers protective effects of hesperidin on functions and integrity of liver, 
kidney, heart, and age related memory impairment. Hesperidin demonstrated the antimicrobial, anticancer, antihypertensive 
and antiulcer effect. The present review focus on current information of hesperidin and its active metabolite hesperetin. 
Along with this, the chemotherapeutic potential of the same has also discussed. 
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Medicinal plants and herbal remedies continue to be 
an important part of the health care system
1
. Herbal 
remedies are a vital part of the healthcare system in 
Afro-Asian and European countries. In the present 
scenario, India, China, Nigeria, and USA as well as 
WHO have made substantial efforts to explore 
therapeutic effects of these remedies
2
. Many synthetic 
molecules share structural homology with various 
natural products that serve as leads
3,4
. Flavonoids are 
one of the important classes of phytochemicals  
that are well accepted for their beneficial effects on 
human health. In plants, flavonoids play a major  
role in protecting from ‗invading infections‘ and  
‗UV radiations5. Flavonoids are widely disseminated 
amongst the ‗plant kingdom‘. They act as signal 
molecules during nodulation, promote auxin transport 
and are responsible for imparting color to flowers 
which aid in pollination
6
. There are more than 4000 
flavonoids present in plant
7
. Fruits, vegetables, nuts, 
tea, wine, etc. are rich sources of flavonoids
8
 which 
form an important part of the diet. The dietary source 
of flavonoids is the leading domain of the research 
owing to their health benefits. The use of flavonoids 
for the promotion of human health finds an interesting 
past. It was observed that the mediterranean 
population consuming red wine and a high saturated 
fat showed low cardiovascular mortality rate made 
researchers to explore therapeutic effects of 
flavonoids
9
. Flavonoids have a wide array of  
bio-spectrum which includes antioxidant, antidiabetic, 
anticancer and anti-human immunodeficiency virus 
effects
10
. Continuous efforts are being made to 
explore the beneficial effects of flavonoids on human 
—————— 
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health. Flavonoids are among the important classes of 
phytoconstituents found in plants. Hesperidin, 
hesperetin, eriodictyol and naringenin, pelargondin, 
peoidin, genistein, glycitein, galangin, kaempferol, 
malvidin, taxifolin, luteolin, apigenin, myricetin, 
catechin, epicatechin, epigallocatechin, theaflavin, 
rhamnazin, fisetin etc are few of the important 
flavonoids which are recognized for varied types of 
biological effects.  
Hesperidin, a flavanone, is abundantly found in the 
rind of citrus fruits. The important sources of 
hesperidin include Agathosma serratifolia (Curtis), 
Citrus aurantium (L.), Citrus sinensis (L.), and  
Citrus limon (L.). Gyrogri, a Hungarian researcher, 
recognised that the intake of ‗citrus peel flavonoids‘ 
effectively averted ‗capillary bleeding‘11. Hesperidin 
is a stable compound. However, it gets degraded in 
the presence of strong oxidizing agents. In general, 
hesperidin is stable below 75C, oxygenless and in a 
neutral or acidic environment. The degradation of 
hesperidin is promoted in the presence of metal ions 
(Cu
2+
, Fe
3+
) and in presence of strong light.  
This review focuses the pharmacological potentials of 
Hesperidinas studied in various experimental models. 
 
Pharmacological Effects 
 
CNS effects 
 
Antiepileptic effects 
Hesperidin has been studied for possible 
antiepileptic effects. Hesperidin cause attenuation of 
mitochondrial, biochemical and behavioural alterations 
inpentylenetetrazole pretreated Laca mice. Further, 
restoration of reduced glutathione, superoxide 
dismutase, and catalase levels was also observed.  
It was observed that the anti-convulsant effect of 
hesperidin was due to γ-amino butyric acid-
benzodiazepine receptor action
12
. In another study by 
the same research group, it was seen that treatment 
with l-arginine (100 mg/kg) or l-N
G
-nitroarginine 
methyl ester (10 mg/kg) significantly enhanced 
neuroprotective effects in combination with hesperidin. 
Hesperidin through NO-cGMP (Nitric oxide-cyclic 
adenosine monophosphate) pathway was found  
to be responsible for neuroprotection
13
. Hesperidin 
attenuated response towards 4-aminopyridine and 
bicucullineon rat hippocampal slice preparations. 
Involvement of large conductance calcium-dependent 
potassium channel for such effects was postulated
14
. 
 
Sedative effect 
Coadministration of alprazolam, bromazepam, 
midazolam and flunitrazepam with hesperidin, 
showed overall potentiation of a sedative effect. The 
selective decrease in the phosphorylation state of 
extracellular signal-regulated kinases 1/2 (ERK 1/2) 
was a crucial factor that was responsible for CNS 
depression
15
. Naltrexone and norbinaltorphimine 
block the sedative effect of hesperidinthat reveals the 
involvement of opioid receptors in mediating this 
effect
16
. Such an effect was enhanced by buspirone 
and yohimbine and regressed by caffeine and 
aminophylline. Involvement of adenosine receptors in 
mediating sedative effects was the key mechanism 
involved in the effect
17
.  
 
Antiparkinson effect 
The intracerebroventricular injection of  
6-hydroxydopamine in aged mice developed ‗Parkinson‘ 
disease-like symptoms. Hesperidin treatment for 28 days 
in this animal showed improvement in behavioural and 
biochemical parameters. Treatment with hesperidin 
averted memory impairment, depression-likebehaviour 
with restoration of depleted glutathione and catalase in 
the ‗striatum‘ of aged mice18. Hesperidin was capable 
of providing relief during the episodes of oxidative 
stress which was possibly due to binding and 
blockade of sulfonylurea receptor 1 (SUR1) and 
reverted stroke like condition in animals
19
. Hesperidin 
administration caused decreased ‗reactive oxygen 
species formation‘, down regulation ofBax, cyt c, and 
caspases 3 and 9, with enhancement in the levels of 
reduced glutathione. There was upregulation of Bcl-2 
demonstrating the antiapoptotic effect (against rotenone-
induced oxidative stress). In another independent study, 
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 
induced Parkinson‘s disease in mice, hesperidin 
treatment appreciably protected ‗microglia activation‘ 
and dwindled the release of inflammatory cytokines 
viz. TNF-α, IL-6, IL-4, and IL-10 in the striatum and 
substantialnigra
20
. Such an effect aided to protect 
striatum and substantial nigra area in brain. 
Antiparkinson effects in Drosophila model were also 
observed due to hesperidin
21
.  
 
Anti-Alzheimer effect 
In APPswe/PS1dE9 transgenic mice (which 
demonstrate increase in parenchymal Aβ load, Aβ 
plaques accumulation commence from 4 months of 
age with glial activation and deficits in cognitive 
functions at 6 months of age), hesperidin 
administration (100 mg/kg per day) for 16 weeks 
resulted in there plenishment of brain antioxidant 
levels (SOD, CAT GPX). There was an increase in 
glycogen synthase kinase-3β (GSK-3β) phosphorylation 
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and mitochondrial complex I-IV enzymes activities 
(compared to Donepezil) revealing its beneficial 
effects
22
. In aluminium chloride treated animals, 
hesperidin administration (orally) decreased 
aluminium concentration, brain acetylcholinesterase 
activity and secretase-related molecules in the brain. 
Behavioral studies showed increased spontaneous 
locomotor and exploratory behaviour in ‗open field 
test‘ along with improved performance in 
morrismaze. Histological studies of the brain also 
supported protective effects on the brain. It was 
postulated that hesperidin chelated aluminium due to 
wich aforementioned protective effects were seen
23
. 
In another study, the role of hesperidin against  
Aβ-induced impairment of glucose utilisationwas 
studied, whereby, improvement in Aβ-impaired 
glucose utilisation by inhibition of Aβ-induced 
autophagy in neuronal cells was observed
24
. 
Hesperidin also suppressed oxidative stress and 
inflammation through the commencement of Akt/Nrf2 
signalling and embarrassment of RAGE/NF-κB 
signalling thus offering neuroprotection in APP/PS1 
mice
25
. Due to high affinity for β-secretase 1 
(BACE1), hesperidin demonstrated complete 
inhibition of the enzyme at a very low concentration 
of 500 nM. Amyloid fibril formation was prevented 
by hesperidin
26
. Antidepressant like effect of 
hesperidin was due to up-regulation of brain-derived 
neurotrophic factor (BDNF) levels (in chronic mild 
stress mice).In a study, hesperidin afford protective 
effect against cognitive impairment (against ischemic 
brain damage)
27
. 
 
Analgesic effect 
Hesperidin demonstrated a significant analgesic 
and anti-inflammatory effectsin experimental animal 
models
28
. Significant anti-nociceptive effect and 
absence of motor in-coordination were observed on its 
oral adminitration to rat. Flumazenil, ketanserin, 
prazosin, yohimbine, caffeine when given 5 min 
before hesperidin administration failed to ‗revert‘ its 
analgesic effects. However, no such effects were 
demonstrated by its aglycone, hesperetin on animals. 
Hesperetin was able to inhibit G-protein-activated 
inwardly rectifying K
+
 channelsand showed a  
weak binding affinity towards μ-opioid receptor29. 
Another study revealed thathesperidin also inhibited 
cyclooxygenase-2 (COX-2) and inducible nitric oxide 
synthase (iNOS)
30
. In the case of NOs, there were 
important docing interactions seen at aspartic  
acid 476, glutamic acid 710, glutamine 712,  
glycine 473, tyrosine 711
31
. In the pain induced 
functional impairment model in the rat,  
hesperidin administration produced a dose-dependent 
antinociceptive response. Similarly, a decrease in time 
spent in paw licking was observed. There was also 
decrease in capsaicin-induced nociceptive response 
which suggested the participation of transient receptor 
potential cation channel subfamily V member 1 
(TrpV1) receptor. Co-administration of hesperidin and 
ketorolac in various combinations produced additive 
and supra-additive effects. The study suggests that such 
a combination may be useful to battle arthritic gout 
type pain (Martínez et al., 2011). By preventing the 
growth of ‗methyl methacrylate radicals‘, it was 
thought that hesperidin was able to suppressess 
‗polyunsaturated fatty acid radicals‘. The study 
suggested a significant role of hesperidin as a strong 
inhibitor of polyunsaturated fatty acid radicals generated 
from reactive oxygen species. The potent embarrassment 
of LPS-induced expression of the COX-2 gene in RAW 
264.7 cells demonstrated anti-noceceptive activity of 
hesperidin (Hirata et al., 2005). Interaction of 
hesperidin with COX-2 enzyme has been well 
studied. Hesperidin treatment caused a noteworthy 
decrement in the levels of PGE2. Effect was 
concentration dependent
30
. 
 
Anti-inflammatory effect 
Anti-inflammatory effects of hesperidin and its 
aglycone hesperetin have been well documented
32
. 
Hesperidin administration resulted in significant  
anti-inflammatory effect on rats in paw oedema model 
(induced by carrageenan). Similar protective effects 
were observed on animals in dextran-induced oedema 
model. Paw oedema was decreased by 33% 3 h after 
hesperidin administration. Carrageenan induced 
pleurisy was also prevented by hesperidin. There was 
a reduction in the volume of exudates and migrating 
leucocyte count was decreased.Similarly, there was a 
decrement in an acetic acid induced abdominal 
constriction in animals, but hesperidin demonstrated 
no effect on tail flick test. A moderate degree of 
antipyretic effect was also observed. Fever was 
lowered after 4 h. Hesperidin demonstrated the 
cytoprotective effect on gastric cells as there were no 
gross lesions on gastric mucosa in animals pretreated 
with hesperidin
33
. 
 
Anti-gout and anti-arthritic effects 
Inhibition of xanthine oxidoreductase enzyme may 
serve to decrease uric acid levels and thus leading to 
anti-hyperuricemic effect. Hesperidin derivatives and 
INDIAN J. BIOCHEM. BIOPHYS., VOL. 56, AUGUST 2019 
 
 
290 
metabolites were studied for possible xanthine 
oxidase inhibitory effect. Kinetics study revealed 
hesperidine to be the competitive inhibitor of xanthine 
oxidoreductase
34
. Hesperetin demonstrated strong 
inhibition of xanthine oxidase with IC50 =53 mΜ. 
Similarly, atherogenic index of hesperetin treated 
group was also significantly low. Another study 
confirmed the a synergistic effect of orange juice and 
hesperetin supplementation in the treatment of gout in 
experimental animals. Allopurinol (standard drug) 
was unable to increase serum antioxidant and 
decrease lipid peroxidation butorange juice (rich in 
hesperidin) mediated such effects
35
. Similarly, 
hesperidin administration in complete Freund's 
adjuvant-induced arthritis in rats resulted in the 
restoration of serum immunoglobulin G, cartilage 
oligomeric matrix protein, serum myeloperoxidase, 
and glutathione. Histopathological analysis of 
hesperidin treated animals revealed restoration of 
‗joint architecture‘36. The antiarthritic effect was 
seendue to suppression of TNF-α and IL-1β in 
synoviocyte proliferation rat adjuvant arthritis model 
37-39
. Similar protective effects were observed with  
α-glucosylhesperidin40. Docking studies of hesperidin 
with TNF-α, IL-1β and IL-6 revealed some crucial 
interactions with these immunomodulatory targets. 
The binding energy of hesperidin for TNF-α was 
−6.96 kcal/mol, there were some important interaction 
which was observed at Serine 69, leucine 120, and 
tyrosine 151 ; with IL-1β the binding energy was 
−6.64 kcal/mol and binding at glutamic acid 37 and 
lysine 65 (1.55 Å) from A chain were observed. In the 
case of IL-6, the binding energy was found to be 
−7.07 kcal/mol with interaction at methionine 67, 
glutamic acid 172 and arginine 179 (B chain)
41
. Similar 
interactions were observed with rutin
31
. Hesperidin 
prevented bone loss in ovariectomized-female rats and 
increase bone mineral density
42
. 
 
Cardiovascular effects 
 
Antihypertensive effects 
Antihypertensive effects of hesperidin and its 
analogues have been extensively studied in animal 
models. Short-term administration of G-hesperidin 
and hesperitin to spontaneously hypertensive rats 
resulted in a dose-dependent showed reduction in 
systolic blood pressure. The combination of enalapril 
or prazosin with hesperidin decreased blood pressure 
significantly which was due to nitric oxide-mediated 
vasodilation
43
. In spontaneously hypertensive rats, 
long-term hesperidin and glucosyl hesperidin 
supplementation in the diet showed regulation of 
blood pressure and heart rate to normal
44
. In  
stroke-prone spontaneously hypertensive rats, 
hesperidin treatment promoted inactivation of NO and 
shielded endothelial function
45
. 
 
Organ protective effects 
 
Hepatoprotective effects 
Hesperidin demonstrated protective effects on 
histo-architecture and cellular integrity of 
hepatocytes. Hesperidin administration in male 
Sprague-Dawley rats exposed to γ-irradiation (1 Gy,  
3 Gy, and 5 Gy) resulted in restoration of ALP  
(alkaline phosphatase), AST (aspartate transaminase), 
ALT (alanine transaminase), (GGT) γ-glutamyl 
transpeptidase, serum ceruloplasmin and LDH (lactate 
dehydrogenase) levels. Histopathological studies were 
in affirmation with this results. Hesperidin (200 mg/kg) 
helped to overcome cellular deterioration, as there 
was no change in ‗lobular structure‘. In 
acetaminophen intoxicated Wistar rats, hesperidin 
administration caused restoration of AST and ALT 
levels which were supported by histological studies
46
. 
Hesperidin demonstrated antifibrotic effects against 
dimethylnitrosamine-induced liver fibrosis in  
rats
47
. Due to enzymatic modification, hesperidin 
demonstrated inhibition of lipid peroxidation and 
restoration of activity of antioxidant enzymes 
providing beneficial effects on ‗alcohol-induced liver 
disease‘48. In another study, hesperidin (80 mg/kg) 
restored biochemical and histochemical changes in 
iron-induced hepatic and renal toxicity in rats
49
.  
An upregulation of heme oxygenase-1 (HO-1) 
expression and activation of ERK1/2 in human 
hepatic L02 cells was observed due to hesperidin 
revealing its protective effect in hydrogen peroxide-
induced damage
50
. Protective effect of hesperidin 
against hepatic steatosis is also observed
51
. 
 
Neuroprotective effect 
Hesperidin and its aglycone hesperetin 
demonstrated neuroprotective effects in various 
experimental models. In a study, administration of  
3-nitropropionic acid in rats for five days (20 mg/kg) 
resulted in decreased locomotor activity, inhibition of 
prepulse and increase in MDA levels (in cortex, 
striatum, and hippocampus). Electron microscopy 
revealed remarkable swelling of mitochondria, 
perivascular oedema and shrinkage of nerve cells in 
untreated rats. All such pathogenies were relieved by 
administration of hesperidin
52
. Similar protective 
results were seen in the case of excitotoxicity induced 
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by kainic acid in the hippocampus of rats
53
. In 
hippocampal whole-cell patch clamp study, hesperidin 
decreased the rate of ‗spontaneous excitatory 
postsynaptic currents‘ without changing ‗amplitude‘54. 
In another study, the integrity of cultured cortical cells 
(against damage produced by ‗H2O2 or xanthine and 
xanthine oxidase‘) was protected by hesperetin55. 
Involvement of L-arginine-NO signalling pathway was 
observed during protective effect of hesperidin against 
cerebral ischemic reperfusion injury
56
. 
 
Retinoprotective effects 
In streptozotocin-induced diabetic rats, hesperidin 
administration to animals for four weeks resulted in 
suppressed ‗blood-retina breakdown‘, the increment 
in thickness of the retina, decreased aldose reductase 
activity and reduction in levels of vascular endothelial 
growth factor. Lipid peroxidation was decreased with 
increment in SOD levels
57
. In rabbit retinal pigment 
epithelial cells culture, hesperidin promoted cell 
growth and prevented NO and iNOS expression
58
. 
Hesperidin treatment resulted in a decrement in retinal 
damage caused due to high glucose levels
59
. 
 
Cardioprotective effect 
Cardioprotective effects of hesperidin against 
various insults have been well documented. In the 
doxorubicin-induced cardiotoxicity model, hesperidin 
administration to rat aided in the reduction of oxidative 
stress, an anomaly in cellular morphology and DNA 
damage. This effect was mediated by suppression  
of NF-κB, caspase-3and p3860. In streptozotocin-
isoproterenol induced cardiotoxicity model, hesperidin 
aided in an increment of GPX, SOD, and CAT.  
Levels of creatine kinase-MB isoenzyme, lactate 
dehydrogenase were also increased. Upregulation of 
PPAR-γ and Bcl-2 along with downregulation of Bax 
was seen. Doxorubicin-induced DNA damage and 
apoptosis were considerably prevented (Agrawal  
et al. 2014a)
61
. Hesperidin also showed protective 
effects in ischemic reperfusion injury model. 
Enrichment of the endogenous antioxidant defence 
system and improved histo-architecture of myocardium 
was observed (Agrawal et al. 2014b)
62
. 
 
Nephroprotective effects 
Hesperidin administration in CCl4 intoxicated 
animals caused attenuation of thiobarbituric acid 
reactive substances (TBARS) and increased levels of 
protective antioxidant enzymes viz. CAT, SOD and 
glutathione
46
. Cisplatin raises total sodium, total 
potassium, and urinary creatinine levels but 
administration of hesperidin in cisplatin intoxicated 
animals aided to restore kidney functions and 
oxidative stress biomarkers. In this study, there was a 
significant refurbishment of serum sodium, serum 
creatinine and blood urea nitrogen in hesperidin 
treated group
63
. In cisplatin induced oxidative stress 
over kidneys, hesperidin administration significantly 
restored the expression of nitric oxide in the kidney. 
There was a decrease in lipid peroxidation, 
inflammation due to infiltration of leukocytes and 
pro-inflammatory cytokine. Necrosis (due to caspase-3 
activity) and DNA damage were prevented
64
. In an 
independent study, gentamicin administration to rats 
altered endogenous antioxidant enzyme system. 
Higher body weight and low kidney weight were 
observed in the same group. Similarly, there was an 
increase in serum creatinine, urea, uric acid and 
TBRAS levels. Hesperidin administration served to be 
fruitful in reverting harmful effects produced by 
gentamicin in rats and restoration of antioxidant 
enzyme levels was observed. The histomorphological 
study revealed normal kidney features with little 
degenerative changes
65
. Similarly, in trichloroethylene-
induced nephrotoxicity model, hesperidin treatment 
decreased kidney malondialdehyde levels and increased 
antioxidant enzymes, creatinine and KIM-1 levels
66
. 
Correspondingly, protective effects of hesperidin on 
kidney integrity and functioning against acetaminophen-
induced toxicity were observed
67
. Nicotine 
administration in rats for 22 weeks altered levels of 
AST, ALT, ALP, and LDH. Hesperidin (25 mg/ kg 
dose) was effective in restoring altered levels of 
enzymes above in kidneys of nicotine intoxicated rats
68
. 
In γ-radiation-induced toxicity in rats, hesperidin 
administration caused little necrotic damage along with 
significant recovery
69,70
.  
 
Radio modulatory effects 
Radiation therapy is one of the main strategies in 
the treatment of cancer, but, due to detrimental effects 
on other healthy tissues, its use is limited. Hesperidin 
has been screened for radioprotective effects in 
animal models. In various studies, hesperidin has 
showed protective effect on ‗γ irradiation in mouse 
bone marrow cells‘71, liver72, and other tissues69. 
Protective effects on human lymphocytes had been 
studied, whereby the deteriorative effect of radiation 
was reverted which was witnessed by the restoration 
of antioxidant enzymes and decrease in TBARS 
levels
73,74
. Protective effect of hesperidin was also 
evaluated against γ-irradiation induced acute renal 
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damage in rats. The restoration in activity of SOD and 
GSH (glutathione)and decreased lipid oxidation was 
seen. The decrease in neurtophils and macrophages 
was also observed
75
.  
 
Protection against testicular toxicity 
Protective effects of hesperidin on testicular 
ischemia/reperfusion injury in rats was observed. 
Levels SOD, CAT and GSHwere restored due to 
hesperidin administration (Celik et al, 2016)
76
. 
Benzo[α] pyrene-induced testicular toxicity was 
ameliorated by hesperidin whereby testis weights 
were increased to normal, there was negligible degree 
of induced pyknosis, necrobiotic changes and 
chromatolysis in the nuclei of the spermatocytes in 
the seminiferous tubules
77
. In another study, harmful 
effects of cisplatin on the reproductive system were 
effectively reversed by hesperidin
78
. G-hesperidin 
demonstrated a protective effect against vanadium, as 
vanadium exposure to testicles caused decreased 
availability of androgens. Thus, oxidative damage to 
testicles was protected due to G-hesperidin 
administration
79
. 
 
Endocrine effects 
 
Antidiabetic and hypoglycemic effects 
In streptozotocin-induced marginal type 1 diabetic 
rats, hesperidin administration in the diet (10 g/kg 
diet) caused a decrement in elevated blood glucose 
levels, with the regulation of adiponectin and lipid 
levels
80
. Protective effects of hesperidin (50  mg/kg, 
orally) over CNS activity on streptozotocin-induced 
diabetic rats were studied where hesperidin treatment 
caused depletion of neurotoxicity biomarkers, and 
neuromodulatory effects were observed
81
. Similar, 
results were observed in high-fat fed/streptozotocin 
induced type 2 diabetic rats. Hesperidin 
supplementation (50 mg/kg, orally for 4 weeks) to 
these animals caused improvement and restoration of 
antioxidant enzyme defence system. Level of 
glycosylated haemoglobin was decreased. There was 
suppression of inflammatory cytokines (TNF-α and 
IL-6)
82
. Another important mechanism responsible for 
the hypoglycemic effect of hesperidin could be 
increased ‗hepatic glycolysis‘ and decreased ‗hepatic 
gluconeogenesis‘83. In pregnant diabetic mice, 
attenuation of maternal glycemia, increased number 
of implantations and an overall number of foetus were 
observed by hesperidin treatment. Histopathological 
analysis of foetus showed no sign of embryopathy in 
hesperidin treated group
84
. There was a significant 
improvement in diabetic nephropathy which was 
observed due to modulation TGF-β1 and oxidative 
DNA damage
85
. 
Hesperetin caused inhibition of glycolytic enzymes 
viz, amylase and glucosidase. For glucosidase IC50 
was 150 μM and for amylase, more than 0.50 mM86.  
 
Antihyperlipidemic effects 
Hesperidin supplementation in laboratory animals 
was associated with lipid-lowering effects in many 
animal models of lipidemia and cholesterolemia.  
The antihypercholesterolemic effects of hesperidin 
(0.066 mM/100 g diet) were associated with 
inhibition of lipidemic enzymes viz. HMG-CoA 
reductase and acyl-CoA:cholesterol acyltransferase. 
Thus the reduction in cholesterol biosynthesis  
and esterification was observed
87
. Another study 
confirmed improvement in fatty liver on hesperidin 
administration (0.08% hesperidin in diet). Expression 
of mRNA for retinol binding protein, cutaneous fatty 
acid-binding protein, and heart fatty acid-binding 
protein was also regulated (Wang et al. 2011)
88
.  
α-Monoglucosyl hesperidin suppress white fat 
accumulation
89
. Co-administration of vitamin C and 
hesperidin was beneficial in reducing the levels of 
cholesterol
90
. Glucosyl hesperidin (30 mg/kg, orally), a 
water soluble analogue of hesperidin aided in the 
improvement of HDL cholesterol synthesis in 
animals. Hypertrophy in vasculature was also 
inhibited
90
. In case of Caenorhabditis elegans,  
100 μM hesperidin decreased the accumulation of fat 
in high-fat worms. The decrease in the regulation of 
stearoyl-CoA desaturase was seen. Expression of  
pod-2, mdt-15, acs-2, and kat-1 genes (lipid 
metabolism regulating genes) was also decreased
91
. 
 
Antithyroid effect 
Hesperidin administration to L-thyroxine (l-T4) 
induced hyperthyroidism in rats caused suppression of 
hepatic 5'DI, serum lactate dehydrogenase and  
serum glutamate pyruvate transaminase. Suppression 
of hydroxyl radical formation in hepatic tissue was 
observed by electro paramagnetic resonance (EPR) 
spectra
92
.  
 
Antiulcer effects 
Hesperidin as well as in combination with other 
drugs/phytochemicals has been evaluated for antiulcer 
effects. In indomethacin-induced peptic ulcers model 
of rats, hesperidin administration increased GSH 
content of stomach
93
. In another study, indomethacin 
and hypothermic restrain stress-induced ulceration 
models were used to assess the antiulcer effects  
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of hesperidin. Hesperidin (300 and 450 mg/kg) 
administration elevated gastric pH with diminution of 
acidity and ulcer index. There was a significant 
increase in the levels of mucin, SOD, CAT, and  
GSH. The protective effect was observed due to 
cytoprotective, muco-protective and antioxidant 
activity
94
.  
 
Antiallergic effects 
In chronic airway inflammation and airway 
remodelling (ovalbumin-induced airway inflammation) 
situation, hesperidin supplementation (5, 10, and  
30 mg/kg) decreased ‗infiltrating inflammatory cells‘ 
count, and ‗Th2 cytokines‘ in alveolar space, serum 
levels of OVA-specific IgE were also decreased. 
There was reduced resistance to inhaled ‗methacholine‘ 
airway hyperresponsiveness in animals. 
Histopathological evidence also supported above 
mentioned protective effects
95
. Ovalbumin (OVA) 
obtained from the chicken egg is an often used 
asallergen to induce allergic pulmonary inflammation 
in laboratory animals. Sensitivity in airways is seen 
soon after inducing allergens to animals. Alum may 
also be combined with OVA to achieve a significant 
degree of inflammation in animals
96
. Antiasthmatic 
effects of hesperidin were due to‘ suppression of 
production of IL-5, IL-17, and OVA-specific IgE‘ 
especially ‗Th2 cytokines (IL-5)‘97.  
 
Chemotherapeutic effects 
 
Antibacterial effects 
Lethal effect of hesperidin against Aeromonas 
hydrophila hasbeen studied in detail. Minimum 
bactericidal concentration was determined and in vivo 
studies on mouse infection model was performed. 
Zone of inhibition was 8 mM for 12.5 mg/mL and  
13 mM for 100 mg/mL concentration. Minimum 
inhibitory concentration and minimum bactericidal 
concentration of hesperidin were found to be 3125 
and 12500, respectively. In mouse infection model, 
bacterial load in untreated group of infected animals 
was 7.842 ± 0.128 Log10 CFU/mL where as it was 
(3.2875 ± 0.085 Log10 CFU/mL in hesperidin treated 
group
98
. Antimicrobial effect of hesperidin on Proteus 
mirabilis and Staphylococcus aureus revealed that  
it‘s MIC90 was 12 times lower when compared to 
chloramphenicol
99
. 
Sulphonated hesperidin demonstrated inhibitory 
effects against Chlamydia trachomatis and Neisseria 
gonorrhea
100
. Hesperitin, a hesperidin aglycone 
demonstrated antibacterial effects against E. coli, 
Pseudomonas putida, Salmonella enterica,  
Gram-positive bacteria Listeria inocula, Bacillus 
subtilis, Staphylococcus aureus, Lactococcus lactis 
above 1000 µg/ mL
101
. Shock due to Salmonella 
typhimurium was suppressed by hesperidin.  
TNF-α and high mobility group box chromosomal 
protein 1 (HMGB-1) expression was suppressed
102
. 
 
Antifungal effects 
Against Saccharomyces cerevisiae, inhibitory 
concentrations of hesperetin above 1000 µg/mL were 
observed
101
. Antifungal effects of hesperidin against 
Aspergillus parasiticus, Aspergillus flavus, Fusarium 
semitectum and Penicillium expansumare well 
documented. Patulin (a mycotoxin) accumulation was 
also prevented
103
. 
 
Antiviral effects 
Inhibition of HIV, and Herpes Simplex virus type 2 
(HSV-2) was observed due to hesperidin 
100
. Inhibitory 
effects over sindbis virus [IC50= 20.50 µg/mL]
104
  
and rotavirus [IC50=10 µM]
105
 has also been studied. 
The Inhibition against canine distemper virus was 
observed
106
. Glucosyl hesperidin, a water-soluble 
derivative of hesperidin, by inhibiting sialidase 
(neuraminidases), prevented Influenza A virus 
replication as evidenced by studies on Madin-Darby 
canine kidney cells
107
. 
 
Antiparasitic effects 
Survival of Brugia malawi was prevented by 
hesperetin. The death of the test organism was 
witnessed. More than 50% MTT reduction was  
seen at 31.22 μg/mL concentration (Lakshmi, et al. 
2010)
108
. 
 
Anthelmintic Effects 
Protective effect of hesperidin against Schistosoma 
mansoni infestation in mice model was studied. 
Hesperidin administration demonstrated a significant 
reduction in ‗worm burden‘ in infected animals. 
‗Schistosoma mansoni specific IgG level‘ in infected 
animals were considerably augmented
109
. 
 
Anticancer effects 
Anticancer study of hesperidin and its analogs  
have been well documented
110,111
. Hesperetin 
administration in a rat model of colon carcinogenes is 
causes a decrease in ‗lipid peroxidation‘ levels in 
colon tissue. Restoration of SOD, CAT, GPX and GR  
was observed
112
. In an independent study, the 
anticarcinogenic effect of hesperidin over benzo (α) 
pyrene induced lung carcinogenesis in mice was 
studied. Benzo (α) pyrene (a carcinogen) administration 
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resulted in an increment in lung specific tumour marker 
carcinoembryonic antigen specifically along with 
increased levels of aryl hydrocarbon hydroxylase, 
lactate dehydrogenase, 5'nucleotidase, and glutamyl-
trans peptidase. Depletion of defensive antioxidant 
enzyme system was observed. Treatment of animals 
with hesperidin revealed ‗potent anticancer effect‘.The 
histopathological analysis also confirmed the same
113
. 
Anticancer effects of hesperidin on Ehrlich solid 
carcinoma were determined on mice model. The 
increment in serum and tissue glutathione and 
decrement in tumour weight and volume was 
observed. Modulation of ‗mdr1a gene expression‘ 
along with the decreased expression of ‗p53 and 
VEGF‘ were possible mechanisms behind it114. In a 
study, hesperidin suppressed of cell proliferation in 
the colonic crypts
115
. Co-treatment of doxorubicin 
and hesperidin MCF-7/Dox cells demonstrated 
synergistic effect possibly due to inhibition of  
P-glycoprotein (Pgp) expression
116
. In gall bladder 
cancer cells, hesperidin treatment resulted in cell 
cycle arrest at G2/M phase
117
. Anticancer effect of 
hesperidin is possibly due to suppression of 
migration and invasion of non-small cell lung cancer 
cells by inhibiting of SDF-1/CXCR-4 pathway
118
. 
Hesperidin treatment resulted in programmed cell 
death which was due to down-regulation of  
non-genomic estrogen receptor signalling pathway in 
endometrial cancer cells
119
. Outcomes of various 
studies about the anticancer effects of hesperidin are 
listed in (Table 1 and Fig. 1). 
 
Immunomodulatory effects 
In irradiated mice, hesperidin supplementation 
resulted in an increase in percentages of ‗CD4(+) and 
CD8(+) lymphocytes‘; a decrease in the levels of 
serum cytokines viz. tumour necrosis factor-α, 
interleukin-6, and interleukin-1β and increase in total 
protein after 30 days of irradiation was observed
120
. 
Effect of hesperidin administration on ‗macrophage‘ 
 
 
Fig. 1 — Anticancer effects of Hesperidin 
Table 1 — Anticancer effects of hesperidin and putative 
mechanisms 
Cell 
line 
Type IC50 Mechanism Reference 
MCF-7 Breast 1.67 µg/mL Cytotoxic 
effect 
111 
HEp-2 Larynx 3.33 µg/mL Cytotoxic 
effect 
111 
HeLa Cervix 4.17 µg/mL Cytotoxic 
effect 
111 
HepG-2 Liver 4.58 µg/mL Cytotoxic 
effect 
111 
SNU-
C4 
Colon 65% cell 
viablilty 
reduction 
Apoptotic 
effect 
112 
COS7 Kidney 29 µg/mL Cytotoxic 
effect 
113 
Ramos Lymphoblast 50 μM Apoptotic 
effect 
114 
MSTO-
211H 
Mesothelioma 152.3 μM Cytotoxic 
effect 
115 
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integrity was observed whereby, decrement in NO,  
IL-10, IL-12, and TNF-α were seen. Suppression  
of inflammatory response was observed
121
. In  
another study,   improvement   in  ‗immunity  and  the 
morphometry of small intestine‘ in lipopolysaccharide 
challenged broiler chickens was observed (Kamboh & 
Zhu 2014)
122
. Immunomodulatory effects and  
anti-infective effects of hesperidin due to Aeromonas 
hydrophilia were observed in the murine model. 
Levels of anti-LPS and anti-ECP IgA levels 
hesperidin treated group were reduced
98
. 
 
Pharmacokinetics 
Hesperidin is well absorbed from the large 
intestine. It has poor bioavailability as compared to 
hesperetin. Hesperidin ((1.51 ± 0.78 × 10
−6
 cm/s) has 
less retina to scleral permeability when compared to 
hesperetin (2.52 ± 0.51 × 10
−6
 cm/s). Hepato-biliary 
elimination of hesperidin takes place against a 
concentration gradient. Glucuronidation and sulphate 
conjugation are important pathways for their metabolism 
(Fig. 2). Hesperetin is one of the important  
active metabolites. Details of various pharmacokinetic 
parameters are summarised in (Table 2). Hesperidin 
(Fig. 3) is stable in acidic media. Some novel 
formulations of hesperidin like nanosuspensions
123
, 
organogel-emulsion
124
, microemulsion
125
 and 
hydroge
126
, gastro-resistant microparticles
127
, dermal 
smartCrystals
®128
, have been formulated for achieving 
better bioavailability. 
 
 
Fig. 2 — Metabolism of hesperidin 
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Fig. 3 — Structure of hesperidin 
 
Table 2 — Pharmacokinetics of Hesperidin 
Absorption Oral 116 
Distribution Widely distributed 117 
Metabolism Deglycosylation 118 
Excretion Faecal 119 
Active metabolite Hesperetin 118 
Half life 6.989±0.258 h 120 
AUC 30.1 nM . h/mL 120 
 
Conclusion 
Hesperidin and its aglycone hesperetin on the 
animal as well as human have demonstrated various 
beneficial, protective and therapeutic effects on 
various biological systems Hesperidin has shown 
antioxidant and radical scavenging effects which 
could be a possible reason behind therapeutic effects. 
Hesperidin aided in the restoration of an antioxidant 
enzyme defence system. Anticancer effects of 
hesperidin and its analogues are due to apoptosis and 
cytotoxic effects. A wide variety of inflammatory 
mediators and their expression has been suppressed 
by hesperidin. The activity of some enzymes is  
also inhibited by hesperidin. Antidiabetic and 
antihypertensive effects of hesperidin are well studied. 
Apart from animal studies, numerous human studies 
have revealed anti-obesity, anti-hyperlipidemic, and 
anti-hemorrhagic effects.  
In the future, hesperidin/hesperetin analogues with 
adequate lipid solubility and unique receptor/enzyme 
binding affinity could be developed that will have 
targeted therapeutic effect on cells and organs.  
Hence, hesperidin can be considered as an ‗essential 
phytochemical‘ which is obligatory to be studied 
comprehensively to establish effective safety profile 
in human to get therapeutic benefits. 
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